CX Institutional’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-134
Closed -$5K 1144
2022
Q2
$5K Buy
+134
New +$5.42K ﹤0.01% 1042
2021
Q4
Sell
-680
Closed -$39K 917
2021
Q3
$39K Buy
680
+15
+2% +$925 ﹤0.01% 624
2021
Q2
$42K Buy
665
+47
+8% +$3.1K ﹤0.01% 596
2021
Q1
$39K Buy
618
+376
+155% +$21.8K ﹤0.01% 547
2020
Q4
$13K Sell
242
-229
-49% -$11.3K ﹤0.01% 695
2020
Q3
$21K Buy
471
+298
+172% +$13.2K ﹤0.01% 537
2020
Q2
$8K Buy
173
+116
+204% +$4.91K ﹤0.01% 604
2020
Q1
$2K Sell
57
-9
-14% -$459 ﹤0.01% 698
2019
Q4
$4K Sell
66
-10
-13% -$558 ﹤0.01% 608
2019
Q3
$4K Sell
76
-4
-5% -$215 ﹤0.01% 644
2019
Q2
$5K Buy
80
+27
+51% +$1.45K ﹤0.01% 624
2019
Q1
$3K Buy
+53
New +$2.33K ﹤0.01% 659

Other funds holding XRAY

CX Institutional's XRAY Position: Q3 2022 in Review

CX Institutional sold out of Dentsply Sirona (XRAY) in Q3 2022, closing a stake of 134 shares — an estimated $5K sold.

CX Institutional first reported a position in XRAY in Q1 2019 and held it in 12 quarters. The position peaked at $42K in Q2 2021. 460 funds tracked by Wall St. Rank hold XRAY as of Q3 2022.

  • CX Institutional reported no remaining Dentsply Sirona position as of Q3 2022 after selling out during the quarter.
  • CX Institutional sold 134 Dentsply Sirona shares in Q3 2022, an estimated $5K.
  • CX Institutional first reported a position in Dentsply Sirona in Q1 2019 and held it in 12 quarters.
  • CX Institutional's Dentsply Sirona position peaked at $42K in Q2 2021.
  • 460 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2022.

Based on CX Institutional's 13F filing for Q3 2022, filed 4 Nov 2022.